{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:41:24Z","timestamp":1790700084540,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.abrep.2022.100464","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T01:43:13Z","timestamp":1666230193000},"page":"100464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Analysis of trends and usage of ICD-10-CM discharge diagnosis codes for poisonings by fentanyl, tramadol, and other synthetic narcotics in emergency department data"],"prefix":"10.1016","volume":"16","author":[{"given":"Shannon M.","family":"Casillas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Mustaquim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Vivolo-Kantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.abrep.2022.100464_b0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/2229-5151.141476","article-title":"Bedside point of care toxicology screens in the ED: Utility and pitfalls","volume":"4","author":"Bhalla","year":"2014","journal-title":"International journal of critical illness and injury science"},{"key":"10.1016\/j.abrep.2022.100464_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103296","article-title":"Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care","volume":"97","author":"Bergstein","year":"2021","journal-title":"The International journal on drug policy"},{"key":"10.1016\/j.abrep.2022.100464_b0015","unstructured":"Centers for Disease Control and Prevention. (2020, December 17). Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. https:\/\/emergency.cdc.gov\/han\/2020\/han00438.asp."},{"key":"10.1016\/j.abrep.2022.100464_b0020","unstructured":"Centers for Disease Control and Prevention. (2021, August 19). National Syndromic Surveillance Program (NSSP): Overview. https:\/\/www.cdc.gov\/nssp\/overview.html."},{"key":"10.1016\/j.abrep.2022.100464_b0025","unstructured":"Centers for Disease Control and Prevention. (2022, July 1). Traceable Opioid Material\u00ae Kits to Improve Laboratory Detection of Synthetic Opioids in the U.S. https:\/\/www.cdc.gov\/nceh\/dls\/erb_opioid_kits.html."},{"key":"10.1016\/j.abrep.2022.100464_b0030","unstructured":"Centers for Medicare and Medicaid Services. (2020). Final FY2021 ICD-10 Code Updates - Summary of Changes \u2013 IPF-PPS. https:\/\/www.cms.gov\/files\/document\/fy-2021-addendum-b-ipf-pps-final-rule-icd-10-code-first-update.pdf."},{"key":"10.1016\/j.abrep.2022.100464_b0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","article-title":"Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'","volume":"46","author":"Ciccarone","year":"2017","journal-title":"The International journal on drug policy"},{"issue":"4","key":"10.1016\/j.abrep.2022.100464_b0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Current opinion in psychiatry"},{"issue":"4","key":"10.1016\/j.abrep.2022.100464_b0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA psychiatry"},{"issue":"4","key":"10.1016\/j.abrep.2022.100464_b0050","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jamapsychiatry.2020.4402","article-title":"Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic","volume":"78","author":"Holland","year":"2021","journal-title":"JAMA psychiatry"},{"issue":"6","key":"10.1016\/j.abrep.2022.100464_b0055","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.annemergmed.2018.01.052","article-title":"Opportunities for Prevention and Intervention of Opioid Overdose in the Emergency Department","volume":"71","author":"Houry","year":"2018","journal-title":"Annals of emergency medicine"},{"issue":"29","key":"10.1016\/j.abrep.2022.100464_b0060","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics - 25 States and the District of Columbia, 2019\u20132020","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR. Morbidity and mortality weekly report"},{"issue":"6","key":"10.1016\/j.abrep.2022.100464_b0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR. Morbidity and mortality weekly report"},{"key":"10.1016\/j.abrep.2022.100464_b0070","unstructured":"National Center for Health Statistics. International classification of diseases, 10th revision, clinical modification (ICD-10-CM). (2022, April 6). https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm.htm."},{"issue":"43","key":"10.1016\/j.abrep.2022.100464_b0075","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016","volume":"66","author":"O'Donnell","year":"2017","journal-title":"MMWR. Morbidity and mortality weekly report"},{"issue":"50","key":"10.1016\/j.abrep.2022.100464_b0080","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls - United States, 2019\u20132020","volume":"70","author":"O'Donnell","year":"2021","journal-title":"MMWR. Morbidity and mortality weekly report"},{"key":"10.1016\/j.abrep.2022.100464_b0085","first-page":"1","article-title":"Trends in characteristics of fentanyl-related poisonings in the United States, 2015\u20132021","author":"Palamar","year":"2022","journal-title":"The American journal of drug and alcohol abuse"},{"key":"10.1016\/j.abrep.2022.100464_b0090","doi-asserted-by":"crossref","unstructured":"Pardo, B., Taylor, J., Caulkins, J. P., Kilmer, B., Reuter, P., & Stein, B.D. (2019). RAND Corporation: The Future of Fentanyl and Other Synthetic Opioids. https:\/\/www.rand.org\/pubs\/research_reports\/RR3117.html.","DOI":"10.7249\/RR3117"},{"key":"10.1016\/j.abrep.2022.100464_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103836","article-title":"Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas","volume":"109","author":"Rezaeiahari","year":"2022","journal-title":"The International journal on drug policy"},{"key":"10.1016\/j.abrep.2022.100464_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109195","article-title":"Emergency Department Drug Surveillance (EDDS) hospital's urinalysis results compared with expanded re-testing by an independent laboratory, a pilot study","volume":"230","author":"Schwartz","year":"2022","journal-title":"Drug and alcohol dependence"},{"key":"10.1016\/j.abrep.2022.100464_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108176","article-title":"Signal of increased opioid overdose during COVID-19 from emergency medical services data","volume":"214","author":"Slavova","year":"2020","journal-title":"Drug and alcohol dependence"},{"key":"10.1016\/j.abrep.2022.100464_b0110","article-title":"A qualitative assessment of circumstances surrounding drug overdose deaths during the early stages of the COVID-19 pandemic","volume":"No 2","author":"Tanz","year":"2022","journal-title":"SUDORS Data Brief"},{"key":"10.1016\/j.abrep.2022.100464_b0115","doi-asserted-by":"crossref","unstructured":"Vivolo-Kantor, A., Pasalic, E., Liu, S., Martinez, P. D., Gladden, R. M., & Overdose Morbidity Team (2021). Defining indicators for drug overdose emergency department visits and hospitalisations in ICD-10-CM coded discharge data.Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention,27(S1), i56\u2013i61. https:\/\/doi.org\/10.1136\/injuryprev-2019-043521.","DOI":"10.1136\/injuryprev-2019-043521"},{"key":"10.1016\/j.abrep.2022.100464_b0120","series-title":"Ggplot2: Elegant graphics for data analysis","author":"Wickham","year":"2016"}],"container-title":["Addictive Behaviors Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853222000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853222000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T04:58:37Z","timestamp":1762491517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352853222000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"alternative-id":["S2352853222000591"],"URL":"https:\/\/doi.org\/10.1016\/j.abrep.2022.100464","relation":{},"ISSN":["2352-8532"],"issn-type":[{"value":"2352-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of trends and usage of ICD-10-CM discharge diagnosis codes for poisonings by fentanyl, tramadol, and other synthetic narcotics in emergency department data","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abrep.2022.100464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100464"}}